TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Total Energy (TE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lactate (LAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and efficacy of BUS for NEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: investigator-assessed progression-free survival (mPFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned limb revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Predictive measures of alcohol outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allied health visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PTSD symptom reductions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Driving disability scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neck pain-free driving
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Interleukin levels (IL-1, IL-1β, IL-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Density of immature mosquitoes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Density of adult mosquitoes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Malaria parasite prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased CROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCF test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute deviations in cross-arch distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of NNRTI‐ PDR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival of patients with NNRTI‐ PDR
Endpoint domain: Mortality/survival
Primary endpoint: Total GSRS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Abdominal pain score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reflux symptoms score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: hyperandrogenemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: reproductive abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: ARR (Annual Relapse Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calculated total blood loss (CTBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Drained blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hidden blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Levels of HbO2 and T-Hb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Levels of D-Hb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Kinesiophobia (TSK score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk flexor muscle endurance (TFE score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early clinical responses (complete skin clearance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Valve thrombosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Residual hyperglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion reaching HbA1c less than 7% and FPG less than 130 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvements in muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of sinus rhythm maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of freedom from MACCEs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Support for identifiable data sharing for direct clinical care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Support for de-identified data sharing for research
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Support for a single NHS mechanism to choose uses of data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Oral hygiene index‐simplified (OHI‐S) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total feeding time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nurse job satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PCA consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decline in inflammatory markers (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiological improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced ventilatory support requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Headset tolerance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall survival after LVAD
Endpoint domain: Mortality/survival
Primary endpoint: e-diary compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: IVC rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost per stillbirth prevented
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of severe coagulation events
Endpoint domain: Adverse events/effects
Primary endpoint: Survival time of the filter pipeline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of postoperative atrial fibrillation (POAF)
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Injury prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of lower pressure pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: gamma EEG spectral power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: beta EEG spectral power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean EI (Erythema Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: subjective reinforcing effects of inhaled gas (liking)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motivational effects (wanting more)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of trachea intubation within 72 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Transition time to mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygenation state (PaO2/FiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of unique veterans served
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of PS visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: veterans' outcomes‐activation, satisfaction, and functioning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lymphatic complications (lymphorrhea or lymphocele formation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: any malignancy associated with tofacitinib treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of gastrointestinal illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: anger severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social and interpersonal functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: changes in depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: changes in anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dehydration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local sweating of the chest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total IPSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean storage symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Exposure time of needles after infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operation time for infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for needle disposal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of reduced visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced use of medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported symptoms of glare and visual impairment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain catastrophizing scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain-free status at 2 h postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retroperitoneal hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Children's pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's fear scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of suspected sinus or atrioventricular node dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of atrial and ventricular pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to pressure injury (PI) occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of sacral pressure injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal incontinence reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Defecation frequency improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total score of ESAS
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Feeling of non-well being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean number of QALYs gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: intention strength
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Achievement of MM status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early recurrence rate of intussusception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean %BF (body fat percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rate based on FLUTS UI subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscular strength (1RM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: localized muscular endurance (LME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Coma Scale (GCS) at arrival at hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum levels of TAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scar improvement based on POSAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quicker epithelization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rates of elective PCI for stable angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of increased annual income
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Probability of having an officially registered business
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Learning of choice‐outcome contingencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-related behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: GP satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of pressure injuries (PIs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: high-frequency heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IL‐6 and HMGB‐1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative tube-inserting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar size six months after the operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Retention of fracture fixation knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of agreement (unweighted kappa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pressure-pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: workshop registration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: invitation recall
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: gastrointestinal side‐effects
Endpoint domain: Adverse events/effects
Primary endpoint: Mean intraoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall HrQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse events during training sessions
Endpoint domain: Adverse events/effects
Primary endpoint: scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: functional disturbance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: technical complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: changes of the marginal bone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum bone metabolism indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary symptom scores of intestinal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CHD risk associated with metabolite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: placebo response magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Goal of treatment achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hepatic steatosis (controlled attenuation parameter)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assistive technology-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Week 52 Clinical Remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Week 52 HEMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: external cleaning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved self-control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved problem solving
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increased social confidence
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: prevalence of physical function disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: HPV colonization in foreskin samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Employment of recommended first aid practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Employment of potentially harmful first aid practices
Endpoint domain: Adverse events/effects
Primary endpoint: Number of segments with perfusion defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time of return of bowel sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in severity of symptoms of disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative results of the polymerase chain reaction (PCR) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Free of cough
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Countermovement jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: worry symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area of papillary dermis covered by collagen and elastic fibres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Levels of fibrillin-rich microfibrils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Levels of fibulin-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cardio-Ankle Vascular Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lipoprotein profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean absolute change in ppFEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean absolute change in SwCl concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in CFQ–R respiratory domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Day 15 response rate for licaminlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Excess Weight Loss (%EWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertension remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophagitis prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: IHCL (Intrahepatic Fat Content)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SAT (Subcutaneous Adipose Tissue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VAT (Visceral Adipose Tissue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Agreement between dyads
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative fentanyl consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Opioid-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory Exchange Ratio (RFO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maternal stress, anxiety, and depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neurodevelopmental outcomes of participating infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day neonatal readmission rate due to jaundice
Endpoint domain: Mortality/survival
Primary endpoint: maternal anxiety mean score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall survival rate of occlusal ART restorations
Endpoint domain: Mortality/survival
Primary endpoint: Total hypoglycaemic attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypoglycaemia-free survival probability
Endpoint domain: Mortality/survival
Primary endpoint: Requirement for oxycodone for breakthrough pain
Endpoint domain: Adverse events/effects